1. Home
  2. SANA vs IMOS Comparison

SANA vs IMOS Comparison

Compare SANA & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

N/A

Current Price

$3.15

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

IMOS

ChipMOS TECHNOLOGIES INC.

N/A

Current Price

$39.82

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SANA
IMOS
Founded
2018
1997
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
SANA
IMOS
Price
$3.15
$39.82
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
1.8M
37.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.64%
EPS Growth
17.24
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.87
Revenue Next Year
N/A
$4.97
P/E Ratio
N/A
$158.35
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$12.78
52 Week High
$6.55
$45.43

Technical Indicators

Market Signals
Indicator
SANA
IMOS
Relative Strength Index (RSI) 31.91 54.97
Support Level $2.85 $16.81
Resistance Level $3.24 $45.24
Average True Range (ATR) 0.26 1.73
MACD -0.08 -0.13
Stochastic Oscillator 6.42 55.18

Price Performance

Historical Comparison
SANA
IMOS

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About IMOS ChipMOS TECHNOLOGIES INC.

ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.

Share on Social Networks: